Clinical Trials Browser

Completed × Mesothelioma × LMB-100 × Clear all

NCT02798536 2022-08-23

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

Phase 1 Completed

21 enrolled 19 charts

Other solid neoplasmThoracic

Mesothelioma